Physician profile
Aimee C Fleury
NPI 1477677417
$1,137.34
in general payments reported to CMS, 2019-2025
14 companies · $145 in 2025
The $145 reported for 2025 was less than what a typical Gynecologic Oncology provider received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $159 · 2020: $76.74 · 2021: $47.15 · 2022: $39.78 · 2023: $351 · 2024: $319 · 2025: $145.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $715 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $715.05 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $403.16 | 2022-2024 | Zejula |
| Allergan, INC. | $140.83 | 2019 | |
| Daiichi Sankyo INC. | $108.65 | 2025 | Datroway, Enhertu |
| Ethicon US, LLC | $101.42 | 2020-2023 | Mega Soft |
| Seagen INC. | $99.99 | 2024 | |
| Aadi Bioscience, INC. | $89.00 | 2024 | Fyarro |
| Tactile Systems Technology INC | $52.28 | 2020-2024 | Flexitouch Plus, Entre Plus |
| Sumitomo Pharma America, INC. | $27.72 | 2024 | Gemtesa |
| Coloplast Corp | $25.99 | 2024 | |
| Spectrum Pharmaceuticals INC. | $21.99 | 2025 | Rolvedon |
| Axonics, INC. | $19.06 | 2021 | |
| Abbvie INC. | $17.80 | 2019 | |
| Becton, Dickinson and Company | $14.93 | 2024 | Arista Ah Flexitip |
| Conmed Corporation | $14.52 | 2025 | Abc Handpieces, Airseal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aimee Fleury listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.